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Abstract 
Review on translocations in lipoblastoma with 
t(2;8)(q31;q12.1) COL3A1/PLAG1, with data on 
clinics, genetics and cytogenetics. 
Identity 
Phylum 
Soft Tissue Tumors: Benign Lipomatous: 
Lipoblastoma 
Clinics and pathology 
Disease 
 is a rapidly growing, benign neoplasm.  
It is a mesenchymal tumor of fetal white fat tissue 
that appears most commonly in children under three 
years of age and affects males three times more often 
than females (McVay et al., 2006).  
It can present anywhere in the body, but is most 
commonly seen in the trunk and extremities. 
Surgical excision is usually curative, with a 
recurrence rate of about 20% (Jimenez, 1986; Hicks 
et al., 2001).  
Histologically, lipoblastoma shows a characteristic 
lobular architecture, with lobules containing 
lipoblasts embedded in a myxoid matrix, whereas 
lipoma is a tumor composed of only mature fat 
without lobulation (Weiss, 1996; Kuhnen et al., 
2002; de Saint Aubain Somerhausen et al., 2008; 
Morerio et al., 2009). 
Cytogenetics 
Cytogenetics Morphological 
t(2;8)(q31;q12.1) 
Genes involved and 
proteins 
COL3A1 
Location 
2q31 
Note 
Mutations in this gene are associated with Ehlers-
Danlos syndrome types IV, and with aortic and 
arterial aneurysms. (Lee et al., 2008; Jeong et al., 
2012) 
DNA / RNA 
The COL3A1 gene, located at chromosome 2q31, 
contains 51 exons spanning 38.43 kb of genomic 
distance. Two transcripts, resulting from the use of 
alternative polyadenylation sites, have been 
identified for this gene (GeneCards 
GCID:GC02P189803 
(http://www.genecards.org/cgi-
bin/carddisp.pl?gene=COL3A1), UniProt P02461-
CO3A1_HUMAN 
(http://www.uniprot.org/uniprot/P02461)). 
Protein 
The gene encodes a protein of 1466 amino acids (aa) 
(138kDa).  
Soft Tissues: Lipoblastoma with t(2;8)(q31;q12.1) 
COL3A1/PLAG1 
Yoshida H, et al. 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(6) 415 
 
The shorter isoform is missing 847-1149 aa.   
The protein is the pro-alpha1 chains of type III 
collagen, a fibrillar collagen that is found in 
extensible connective tissues such as skin, lung, 
uterus, intestine and the vascular system, and is 
frequently found in association with type I collagen. 
The C-terminal propeptide, also known as the 
COLFI domain, has crucial roles in tissue growth 
and repair, in which it controls both the intracellular 
assembly of procollagen molecules and the 
extracellular assembly of collagen fibrils. It binds a 
calcium ion which is essential for its function 
(GeneCards 
GCID:GC02P189803(http://www.genecards.org/cgi
-bin/carddisp.pl?gene=COL3A1), UniProt P02461-
CO3A1_HUMAN 
(http://www.uniprot.org/uniprot/P02461)). 
PLAG1 
Location 
8q12.1 
DNA / RNA 
The gene spans about 50 kb and includes 5 exons. 
The size of the transcript is about 7 kb. It has two 
alternative splicing forms (one without exon 2) 
(GeneCards GCID:GC08M057073 
(http://www.genecards.org/cgi-
bin/carddisp.pl?gene=PLAG1), UniProt Q6DJT9-
PLAG1_HUMAN 
(http://www.uniprot.org/uniprot/Q6DJT9)). 
Protein 
The gene encodes a 500-aa zinc finger protein (74 
kDa) with two putative nuclear localization signals 
(Kas et al., 1997). When activated, it acts as a 
transcription factor that up-regulates target genes, 
such as IGFII, leading to uncontrolled cell 
proliferation. When overexpressed in cultured cells, 
it increases the proliferation rate and transformation. 
Other target genes such as CRLF1, CRABP2, 
CRIP2, PIGF are strongly induced in cells with 
PLAG1 induction. PLAG1 is a proto-oncogene 
whose ectopic expression can trigger the 
development of lipoblastomas and pleomorphic 
adenomas of the salivary gland (Hensen et al., 2002; 
Voz et al., 2004; Zatkova et al., 2004) (GeneCards 
GCID:GC08M057073 
(http://www.genecards.org/cgi-
bin/carddisp.pl?gene=PLAG1), UniProt Q6DJT9-
PLAG1_HUMAN 
(http://www.uniprot.org/uniprot/Q6DJT9)). 
Result of the chromosomal 
anomaly 
Hybrid Gene 
The fusion occurs as a result of a cryptic, 
intrachromosomal rearrangement in tumors with 
apparently normal karyotypes. Comparison of the 
fusion gene with the wild type reveals that the fusion 
gene is associated with the t(2;8)(q31;q12.1) 
translocation. The first exon of COL3A1 is fused to 
either exon 2 or exon 3 of PLAG1 (Yoshida et al., 
2014). 
Description 
PLAG1 has a genomic fusion breakpoint in intron 1 
resulting in alternative splicing of exon 2.  
The start codon of PLAG1 is located in exon 4 (Van 
Dyck et al., 2007), and the coding sequence of 
PLAG1 is preserved (Yoshida et al., 2014). This 
supports the molecular mechanism of 
overexpression of PLAG1 through promoter 
swapping: as a result of the translocation, the 
constitutively active promoter of the partner gene 
drives the ectopic expression of PLAG1 (Hibbard et 
al., 2000) 
Detection 
RT-PCR using total RNA extracted from frozen 
tumor tissue. The COL3A1/PLAG1 fusion transcript 
was amplified with primers 5'-
AGGGGAGCTGGCTACCCTCC-3' (forward), and, 
5'-ACGTTTCCCTGAAGGGACTT-3' (reverse). 
COL3A1/PLAG1-fusion transcripts of 345 bp and 
450 bp were detected (Yoshida et al., 2014). 
Fusion Protein 
Note 
No fusion protein exist for reasons the above. 
Expression / Localisation 
PLAG1 protein localizes to the nucleus (Bahrami et 
al.,2012). 
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